Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation-Reference-Cited by-同舟云学术

Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation

Published:2000-09 Issue:3 Volume:36 Page:685-692
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Hasdai David,Harrington Robert A.,Hochman Judith S.,Califf Robert M.,Battler Alexander,Box James W.,Simoons Maarten L.,Deckers Jaap,Topol Eric J.,Holmes David R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes;N Engl J Med,1996

2. Cardiogenic shock complicating myocardial infarction;Killip;J Am Coll Cardiol,1989

3. An international, randomized, controlled trial of lamifiban, a platelet glycoprotein IIb/IIIa inhibitor, heparin or both in unstable angina;Circulation,1998

4. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina;Lancet,1997

5. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina;N Engl J Med,1998

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycoprotein IIb/IIIa inhibitor use in cardiogenic shock complicating myocardial infarction: The Portuguese Registry of Acute Coronary Syndromes;Revista Portuguesa de Cardiologia;2023-02

2. Trends, Advantages and Disadvantages in Combined Extracorporeal Lung and Kidney Support From a Technical Point of View;Frontiers in Medical Technology;2022-06-21

3. Nomogram for Predicting In-Hospital Mortality in Patients with Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock after Primary Percutaneous Coronary Intervention;Journal of Interventional Cardiology;2022-03-12

4. A Risk Stratification Scheme for In-Hospital Cardiogenic Shock in Patients With Acute Myocardial Infarction;Frontiers in Cardiovascular Medicine;2022-03-04

5. One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock;Journal of Clinical Medicine;2021-10-29